← All stocks

Travere Therapeutics, Inc.

TVTX Mostly scheduled

CIK 0001438533 #1223 in the set updated 21 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$104.49M

$10.46M on a plan · $92.52M straight out of an exercise

Sold at will

$1.51M

8 of 122 sales

Net

−$104.49M

−$1.51M against sales at will

By person

16 insiders · 122 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Dube Eric M

CHIEF EXECUTIVE OFFICER

—

$41.35M (21) scheduled

−$41.35M

432,886

0.4592%

$28.12M

+19.6%

Heerma Peter

EVP, CHIEF COMMERCIAL OFFICER

—

$18.97M (13) scheduled

−$18.97M

117,066

0.1242%

$7.60M

+7.1%

ROTE WILLIAM E.

Chief Research Officer

—

$16.43M (10) scheduled

−$16.43M

98,197

0.1042%

$6.38M

+12.8%

REED ELIZABETH E

Chief Legal Officer and GC

—

$7.27M (20) scheduled

−$7.27M

105,389

0.1118%

$6.85M

+31.2%

Inrig Jula

EVP, Head of R&D & CMO

—

$5.16M (15) scheduled

−$5.16M

100,491

0.1066%

$6.53M

+62.2%

Cline Christopher R.

CHIEF FINANCIAL OFFICER

—

$4.64M (15) scheduled

−$4.64M

87,508

0.0928%

$5.68M

+17.3%

Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

—

$4.19M (8) scheduled

−$4.19M

42,353

0.0449%

$2.75M

−18.6%

Baynes Roy D.

Director

—

$2.55M (6) scheduled

−$2.55M

41,500

0.0440%

$2.70M

+33.9%

Meckler Jeffrey A

Director

—

$1.71M (5) scheduled

−$1.71M

91,500

0.0971%

$5.94M

+13.0%

Coughlin Timothy

Director

—

$1.27M (3) scheduled

−$1.27M

56,250

0.0597%

$3.65M

+14.8%

LYONS GARY A

Director

—

$961.41K (6) scheduled

−$961.41K

61,500

0.0652%

$3.99M

+20.6%

Squarer Ron

Director

—

39,375

0.0418%

$2.56M

+36.4%

Orwin John A

Director

—

39,375

0.0418%

$2.56M

+36.4%

Poole Sandra

Director

—

34,000

0.0361%

$2.21M

+44.7%

Bruhn Suzanne Louise

Director

—

32,750

0.0347%

$2.13M

+47.2%

Williams Brinkley Ruth

Director

—

29,750

0.0316%

$1.93M

+54.5%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Cline Christopher R.

2 Sep 2026

CHIEF FINANCIAL OFFICER

Sell

642

$66.37

$42.61K

Heerma Peter

5 May 2026

CHIEF COMMERCIAL OFFICER

Sell

2,174

$46.65

$101.42K

Heerma Peter

14 Apr 2026

CHIEF COMMERCIAL OFFICER

Sell

7,215

$41.93

$302.52K

REED ELIZABETH E

3 Feb 2026

Chief Legal Officer and GC

Sell

7,175

$32.12

$230.46K

Calvin Sandra

3 Feb 2026

SVP, CHIEF ACCOUNTING OFFICER

Sell

4,333

$32.12

$139.18K

Heerma Peter

3 Feb 2026

CHIEF COMMERCIAL OFFICER

Sell

7,310

$32.12

$234.80K

Cline Christopher R.

3 Feb 2026

CHIEF FINANCIAL OFFICER

Sell

7,242

$32.12

$232.61K

Inrig Jula

3 Feb 2026

CHIEF MEDICAL OFFICER

Sell

6,956

$32.12

$223.43K

Show all 122 transactions →

What was left out

Form 4 filings counted 74

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 37

Sales straight out of an exercise 77

Sales at will 8

Transactions with no price 0

Shares from compensation/vesting 2,152,206

History held since 2 Sep 2016